PEVERELL CLINIC LIMITED

PEVERELL CLINIC LIMITED

PEVERELL CLINIC LIMITED - Company Information

Print Friendly Version

Silverfin false 31/12/2022 31/12/2022 01/01/2022 The principal activity of the Company during the financial year was that of an alternative medicine and therapy clinic. Dr R G Benjafield 10/12/2003 Mrs J Benjafied 10/12/2003 04990755 2022-12-31 04990755 bus:Director1 2022-12-31 04990755 bus:Director2 2022-12-31 04990755 2021-12-31 04990755 core:CurrentFinancialInstruments 2022-12-31 04990755 core:CurrentFinancialInstruments 2021-12-31 04990755 core:Non-currentFinancialInstruments 2022-12-31 04990755 core:Non-currentFinancialInstruments 2021-12-31 04990755 2022-01-01 2022-12-31 04990755 bus:Micro-entities 2022-01-01 2022-12-31 04990755 bus:FullAccounts 2022-01-01 2022-12-31 04990755 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 04990755 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 04990755 bus:Director1 2022-01-01 2022-12-31 04990755 bus:Director2 2022-01-01 2022-12-31 04990755 2021-01-01 2021-12-31 iso4217:GBP xbrli:pure

Company No: 04990755 (England and Wales)

PEVERELL CLINIC LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2022
Pages for filing with the registrar

PEVERELL CLINIC LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 December 2022

Contents

PEVERELL CLINIC LIMITED

BALANCE SHEET

As at 31 December 2022
PEVERELL CLINIC LIMITED

BALANCE SHEET (continued)

For the financial year ended 31 December 2022
2022 2021
£ £
Fixed assets 205,947 206,259
Current assets 43,716 48,285
Prepayments and accrued income 621 526
Creditors: amounts falling due within one year ( 17,639) ( 17,208)
Net current assets 26,698 31,603
Total assets less current liabilities 232,645 237,862
Creditors: amounts falling due after more than one year ( 60,789) ( 74,076)
Accruals and deferred income ( 2,365) ( 2,310)
Net assets 169,491 161,476
Capital and reserves 169,491 161,476

For the financial year ending 31 December 2022 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

  • The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
  • These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
  • These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Peverell Clinic Limited (registered number: 04990755) were approved and authorised for issue by the Board of Directors on 10 June 2023 and were signed on its behalf by:

Dr R G Benjafield
Director
PEVERELL CLINIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2022
PEVERELL CLINIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 December 2022

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 04990755). The address of its registered office is C/O Francis Clark Llp Melville Building East, Royal William Yard, Plymouth, PL1 3RP, United Kingdom.

The address of the principle place of business is 14 Vapron Road, Mannamead, Plymouth, Devon, PL3 5NJ, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 "The Financial Reporting Standard application to Micro-entities Regime".

2. Employees

2022 2021
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors - -

3. Directors’ benefits: advances, credit and guarantees

Advances

During the year the Company advanced £11,080 to Directors 1 and 2 (2021 - £11,080), of which £9,932 was repaid (2021 - £12,624). Interest was not charged on this amount and the balance is repayable on demand. The balance owed by the directors as at 31 December 2022 is £2,395 (2021 - £1,247).